Joann Donnel, LNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 365 Montauk Ave, New London, CT 06320 Phone: 860-442-0711 |
Kiersten Rooney, Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 3 Shaws Cv, New London, CT 06320 Phone: 860-443-4148 |
Mrs. Madelyne Jane Greif, LNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 270 Mohegan Ave, Connecticut College Student Health Service, New London, CT 06320 Phone: 860-439-2288 |
Virginie Eklund, Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 194 Howard St, New London, CT 06320 Phone: 860-443-5130 |
News Archive
The U.S. Food and Drug Administration today approved the first generic versions of Risperdal (risperidone) tablets. Risperdal is an antipsychotic drug used for the treatment of schizophrenia, bipolar disorder, and other psychiatric conditions.
Advaxis, Inc., the live, attenuated Listeria monocytogenes (Lm) immunotherapy company, has updated the survival information from its phase 1 trial of ADXS11-001 which assessed the safety of this agent in advanced, metastatic, progressive cervix cancer in women whose disease progressed subsequent to treatment with cytotoxic therapy.
The State Government of NSW has decided upon a $15 million replacement of nearly 100 school gas heaters especially targeting cold climate areas of NSW. The New South Wales Teachers Federation said in a statement that they will be urging the government to expand the programme to other areas replacing the unflued gas heaters in schools.
An injury to the anterior cruciate ligament is fairly common, especially among young athletes. While it can often be corrected through surgery, the injury can lead to increased risk of developing degenerative joint diseases, including osteoarthritis. The problem is that fluid in the knee joint, which lubricates the cartilage, is impacted by the trauma of the injury and begins to deteriorate.
Highly-focused stereotactic body radiation therapy (SBRT) can eliminate the targeted tumor while avoiding treatment-related illness and may ultimately improve survival for patients with inoperable non-small cell lung cancer, according to early findings of a Radiation Therapy Oncology Group study published in the March 17 cancer-themed issue of the Journal of the American Medical Association.
› Verified 3 days ago